These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 29611400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH, Choi JW, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Shin SY, Lee CK.
    Yonsei Med J; 2017 May; 58(3):552-556. PubMed ID: 28332360
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H.
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [Abstract] [Full Text] [Related]

  • 8. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS, Shih SC, Wang HY, Lin CC, Chang CW, Chen MJ.
    BMC Gastroenterol; 2017 Jan 31; 17(1):22. PubMed ID: 28137301
    [Abstract] [Full Text] [Related]

  • 9. Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: a meta-analysis.
    Su QM, Ye XG.
    World J Gastroenterol; 2012 Nov 21; 18(43):6290-301. PubMed ID: 23180951
    [Abstract] [Full Text] [Related]

  • 10. Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B.
    Kim YM, Shin HP, Lee JI, Joo KR, Cha JM, Jeon JW, Yoon JY, Kwak MS.
    Saudi J Gastroenterol; 2018 Nov 21; 24(6):326-335. PubMed ID: 30004042
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis.
    Yang SS, Cai CW, Ma XQ, Xu J, Yu CB.
    Hepatobiliary Pancreat Dis Int; 2020 Dec 21; 19(6):507-514. PubMed ID: 33051132
    [Abstract] [Full Text] [Related]

  • 12. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N, Xu JH, Yu M, Wang S, Si CW, Yu YY.
    World J Gastroenterol; 2015 Nov 21; 21(43):12421-9. PubMed ID: 26604649
    [Abstract] [Full Text] [Related]

  • 13. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    Wang X, Liu X, Dang Z, Yu L, Jiang Y, Wang X, Yan Z.
    Gut Liver; 2020 Mar 15; 14(2):232-247. PubMed ID: 31158948
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
    Wang GL, Liu Y, Qiu P, Zhou SF, Xu LF, Wen P, Wen JB, Xiao XZ.
    Eur Rev Med Pharmacol Sci; 2016 Mar 15; 20(5):866-72. PubMed ID: 27010143
    [Abstract] [Full Text] [Related]

  • 15. Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.
    Chien RN, Peng CY, Kao JH, Hu TH, Lin CC, Hu CT, Chen CY, Hsieh TY, Lin HC, Chuang WL, Taiwan NA-Registry Group.
    J Gastroenterol Hepatol; 2014 Jan 15; 29(1):185-92. PubMed ID: 24354995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR, Yim HJ, Kang S, Suh SJ, Kim SY, Hyun JJ, Koo JS, Kim JH, Seo YS, Yeon JE, Lee SW, Byun KS, Um SH.
    Liver Int; 2015 Mar 15; 35(3):860-9. PubMed ID: 24905912
    [Abstract] [Full Text] [Related]

  • 20. Virologic response and safety of tenofovir versus entecavir in treatment-naïve chronic Hepatitis B patients.
    Yu HM, Kwon SY, Kim J, Chung HA, Kwon SW, Jeong TG, An SH, Jeong GW, Yun SU, Min JK, Kim JH, Choe WH.
    Saudi J Gastroenterol; 2015 Mar 15; 21(3):146-51. PubMed ID: 26021773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.